Limited time: First month $197 (save $100). Your transformation starts here.

ZenOryva.
ZenOryva.
Take the Assessment
Condition

Obesity

Quick answer

Obesity is a chronic medical condition characterized by excess body fat and a BMI of 30 or higher. The most effective evidence-based treatment combines GLP-1 receptor agonist medication, dietary changes, and behavior coaching. ZenOryva offers doctor-supervised compounded semaglutide and tirzepatide alongside one-on-one coaching for sustained results.

About Obesity

Obesity is recognized by the medical community as a chronic, relapsing disease that affects roughly 42% of US adults. It significantly increases the risk of type 2 diabetes, cardiovascular disease, fatty liver, sleep apnea, and many cancers. The good news: modern GLP-1 medications combined with lifestyle support produce 15 to 20% body-weight reductions on average.

Common signs & symptoms

  • BMI of 30 or higher
  • Difficulty losing weight despite diet and exercise
  • Joint pain related to excess weight
  • Sleep disturbances or snoring
  • Insulin resistance markers

Risk factors

  • Family history of obesity
  • Sedentary lifestyle
  • Diets high in processed food
  • Hormonal changes (e.g., menopause)
  • Certain medications
  • Insufficient sleep

Treatments at ZenOryva

Common questions

Is obesity really a disease?

Yes — major medical organizations including the American Medical Association and WHO recognize obesity as a chronic disease, not a character flaw. It has clear physiological, genetic, and hormonal drivers.

How effective are GLP-1 medications for obesity?

Phase 3 trials of semaglutide and tirzepatide have shown 15 to 22% average body-weight loss over 68 to 72 weeks when combined with lifestyle support.

See if treatment is right for you

Take our 2-minute assessment to get matched with a personalized protocol.

Take the Free Assessment